Role of Candidate Genes Regulating Uterine Prostaglandins Biosynthesis for Maternal Recognition of Pregnancy in Domestic Animals by Sanjeev Kumar Sharma et al.
Hindawi Publishing Corporation
ISRN Physiology
Volume 2013, Article ID 854572, 8 pages
http://dx.doi.org/10.1155/2013/854572
Review Article
Role of Candidate Genes Regulating Uterine
Prostaglandins Biosynthesis for Maternal Recognition of
Pregnancy in Domestic Animals
Rohit Kumar,
1,2 P. W. Ramteke,
1 Amar Nath,
3 R. Kumar Pramod,
2 Satyendra P. Singh,
4
Sanjeev Kumar Sharma,
2 and Sandeep Kumar
5
1 Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad 211007, India
2Animal Genetics Division, Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, India
3Division of Surgery, Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, India
4Department of Animal Genetics and Breeding, College of Veterinary Science and Animal Husbandry, DUVASU,
Mathura 281001, India
5Animal Nutrition Division, Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, India
Correspondence should be addressed to Rohit Kumar; rohit2005biotec@gmail.com
Received 24 March 2013; Accepted 19 April 2013
Academic Editors: A. T. Grazul-Bilska, K. Shirasuna, and D. Xiao
Copyright © 2013 Rohit Kumar et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thesurvivabilityandopportunityofsuccessfuldevelopmentofanembryoareinfluenceddirectlyorindirectlybyfactorscontrolling
uterine microenvironment. Out of all factors, hormones such as prostaglandins (PGs) released during the preimplantation period
influencemolecularinteractionsinvolvedinmaintenanceofpregnancythroughreciprocalinteractionsbetweentheconceptusand
endometrium. PGs are important regulators of female reproductive functions, namely, ovulation, uterine receptivity, implantation,
and parturition. Among different classes of PGs, prostaglandin F2𝗼 (PGF2𝗼) and prostaglandin E2 (PGE2) are main prostanoids
producedbyhumanandbovineendometriumforsuccessfulgrowthanddevelopmentoftheposthatchingblastocyst.Inruminants,
PGF2𝗼 produced by endometrium is the major luteolytic agent, whereas PGE2 has luteoprotective and antiluteolytic properties.
Therefore, the development and maintenance of the corpus luteum (CL), as well as establishment of pregnancy, depend on the
balance of luteolytic PGF2𝗼 and luteotropic PGE2. In this review, we discussed the expression and function of genes which
predominantly regulate the synthesis and their secretion of PGF2𝗼 and PGES, namely, PGFS (AKR1B5/AKR1C3), PGES, PGFR,
and COX-2.
1. Introduction
Successful embryo development and survival include forma-
tion of blastocyst, implantation into the uterus, formation
of placenta, development of the heart, and vascularisation
of both embryo and fetus to assist nutrient deliverance [1].
Among these developmental events, implantation of embryo
is a crucial step and its success mostly depends on the
efficiency with which the maternal recognition of pregnancy
(MRP)isestablished[2,3].TheMRPincludesseriesofevents
that are synchronized by the endocrine interaction between
the mother and the embryo.
The majority of studies examining the molecular mecha-
nismsofconceptus-endometrialinteractionscarriedoutdur-
ing the peri-implantation period of pregnancy have focused
onthematernalside,describingchangesinthetranscriptome
oftheendometrium[4,5].Majorfactoraffectinggeneexpres-
sion in the endometrium is day of the estrous cycle/early
pregnancy. In other words, irrespective of pregnancy status,
thetemporalchangesingeneexpressionintheendometrium
are similar in pregnant and cyclic animals up to the time of
MRP [5, 6].
The survivability and opportunity of successful develop-
ment of an embryo are influenced directly and indirectly by2 ISRN Physiology
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Figure 1: Selective representation for production of PGE2 and PGF2𝗼. Steps involved (i) release of arachidonic acid (AA) from plasma
membrane phospholipids through cytosolic phospholipase A2 (cPLA2). (ii) Conversion of AA into PGH2, the common precursor for all
PGs, occurs through PGH synthase/COX, for which there are two isoforms COX-1 and COX-2. (iii) Conversion of PGH2 into active PG by
terminal synthase PGES and PGFS.
various paracrine and autocrine factors (steroid hormones,
growth factors, and cytokines), controlling uterine microen-
vironment[7].Outofthesefactors,hormonessuchasPGF2𝗼,
PGE2 released during the preimplantation period influence
molecularinteractionsinvolvedinmaintenanceofpregnancy
through reciprocal interactions between the conceptus and
endometrium [8]. Proteome and transcriptome studies have
revealed quantitative and qualitative changes in the genes at
different stages of the estrous cycle and pregnancy [8–12].
These spatial and temporal changes were mainly due to the
expressionpatternofsetsofgenesintheuterineenvironment,
where the endometrium is especially important for the
embryo-maternal interaction and successful establishment
of pregnancy. A number of important candidate genes have
been identified, which regulate estrous cycle through PGF2𝗼
andPGE2production,namely,AKR1B5,PGFS,PGFR,PGES,
and COX-2.
In ruminants, endometrial prostaglandins (PGs) are
important regulators of estrous cycles, uterine receptivity,
implantation,andparturition[13].TwotypesofPGs,namely,
PGF2𝗼 a n dP G E 2a r ek n o w nt oi n d u c eo p p o s i t ee ff e c t si n
tissues such as kidney (human), vascular system (human),
uterine myometrium (pig, cow), and corpus luteum (CL)
(pig) [13]. In ruminants, PGF2𝗼 a n dP G E 2a r et h ep r i m a r y
PGs produced in the uterine endometrium, but their secre-
tory patterns are different [14, 15]. In ruminants, PGF2𝗼 of
u t e r i n eo r i g i ni sr e s p o n s i b l ef o rl u t e o l y s i s ,a n dh i g hl e v e l so f
PGF2𝗼 can disturb pregnancy at any time in several species
(namely human horse pig, sheep, and cow) [16]. Luteolysis,
defined as functional and/or structural regression of CL, is
ak e yp r o c e s si no v a r i a nc y c l e[ 17, 18]. In domestic species,
luteolysis must be initiated to permit a new ovarian cycle
to begin when conception does not occur. Conversely, the
function and integrity of CL are required to establish and
maintain pregnancy. The conceptus must therefore somehow
abrogate luteolysis, a process commonly referred to as the
MRP [17, 18]. In contrast to PGES, PGE2 induces systematic
effects and acts as a luteotrophic or antiluteolytic agent [19].
PGE2 also exerts an immunomodulation that helps prevent
rejectionoftheconceptus[20].ThePGE2/PGF2𝗼ratioaffects
CL function, endometrial cell growth and differentiation,
blood flow, vascular permeability, embryo migration, and
implantation [21].
PGs are produced in response to a variety of physio-
logical and pathological stimuli that activate phospholipase
A2, resulting in the hydrolytic release of arachidonic acid
(AA) from membrane phospholipids [22–25]. AA is then
metabolizedtotheunstablecyclicendoperoxidePGH2bythe
cyclooxygenase enzymes COX-1 and COX-2 (also known as
prostaglandin G/H synthases PGHS-1 and PGHS-2). In cows
and sheep, endometrial COX-2 expression was found to be
transiently induced during late diestrus around the expected
time of luteolysis, whereas COX-1 expression was found to
be invariant (in sheep) or undetectable (in cows) throughout
the estrous cycle [26, 27]. Therefore, cyclooxygenase (COX)
is the rate-limiting enzyme that catalyses the initial step in
prostaglandins (PGs) production [28].
2. Biosynthetic Pathway of PGF2𝗼 and PGE2
PGs are synthesized in the cell from the essential fatty
acids. PGH2, the common precursor of all PGs, is gen-
erated from AA by prostaglandin synthase/cyclooxygenase
(PGHS/COX). However, AA is created from membrane
phospholipids (phospholipase-A2) in the presence of cytoso-
lic phospholipase A2 (cPLA2) [29]. AA is then metabolized
to the unstable cyclic endoperoxide PGH2 by the COX-1 and
COX-2 enzymes (Figure 1). Therefore, COX is an enzymeISRN Physiology 3
that is responsible for the formation of PGs. There are two
isoforms encoded by distinct genes [30]: the constitutive
isoform, COX-1, is widely expressed in a variety of tissues
a n dc e l l s ,w h e r e a st h ei n d u c i b l ef o r m ,C O X - 2 ,i sr e g u l a t e d
by factors such as cytokines or tumor promoters [31]. COX-
1 is constitutively expressed in most tissues and responsible
forhousekeepingfunctionsandimmediateresponsetolevels
of AA above 10𝜇M .C O X - 2i sr e g u l a t e db yf a c t o r ss u c h
as cytokines or tumour promoters and supports sustained
production of PGs from relatively low levels of AA (below
2.5𝜇M) [32]. PGH2 produced by COXs is the common
precursor for generation of primary PGs including PGE2,
PGF2𝗼, by cell-specific isomerases and synthases (such as
PGES for PGE2 and PGFS for PGF2𝗼). The downstream
enzymes, PGE synthase (PGES) and PGF synthase (PGFS),
catalyze the conversion of PGH2 to PGE2 and PGF2𝗼,
respectively.
Among the different PGs, PGE2 and PGF2𝗼 are the
main prostanoids produced in the human [33, 34]a n d
bovine [35] endometrium. The physiological importance of
PGs in reproduction has been confirmed in the mouse,
wheretargeteddisruptionofCOX-1orCOX-2genesreduced
reproductive efficiency [36–38]. Null mutation for cPLA2, a
PG biosynthesis enzyme upstream of COX-2, also leads to
an infertile phenotype [39]. COX is the rate-limiting enzyme
that catalyses the initial step in prostaglandins production
[28]. At the receptor level, deletion of the PGF2𝗼 receptor
(PGFR) showed that it is necessary for parturition in the
mouse [40]. Here, we review the genes responsible for
regulation and maintenance of estrus cycle through PGs
production.
2.1. Prostaglandin F2𝗼 (AKR1C3 and AKR1B5). Among dif-
ferent classes of PGs, PGF2𝗼 is one of the main prostanoids
produced by bovine endometrium [35]. In ruminants, it
regulates ovarian cycle through initiating the regression
(luteolysis) of CL and functions as major luteolytic agent [17,
41]. In particular, PGF2𝗼 is involved in labor and luteolysis
to initiate a new estrous cycle in many species. Apart from
sex steroids, prostaglandins are probably the most important
regulatorsoffemalereproductivefunction(ovulation,uterine
receptivity, implantation, and parturition) and associated
pathologies[42].PGF2𝗼ca nbep r od ucedfr o mthr eedis tinct
pathways(Figure2).ThemajorrouteintheformationPGF2𝗼
is via reduction of PGH2 by 9, 11-endoperoxide reductase
activity, referred to as PGF2𝗼-synthetase (PGSF). PGFS, a
monomeric enzyme, catalyzes the conversion of PGH2 to
PGF2𝗼. PGFS expression has been demonstrated in several
tissues,namely,uterus[43],placenta[44],CL[41],lungs[45],
and liver [46].
Several PGFS have been identified; three were isolated
in the bovine: lung type prostaglandin F synthase (PGFS1)
[45], lung type PGFS found in liver (PGFS2) [46], and liver
type PGFS, also called dihydrodiol dehydrogenase 3 (DDBX)
[47, 48]. Others were also identified, respectively, in human
(AKR1C3) [49], sheep [50], Trypanosoma brucei [51], and
recently in the porcine endometrium [52].
All recognized mammalian PGFSs belong to the aldoke-
toreductase (AKR) 1C family and are generally associated
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Figure2:Knownbiosyntheticpathwaysleadingtotheformationof
PGF2𝗼.
with hydroxysteroid dehydrogenase (HSD) activity [29]. The
membersofAKR1C3playanimportantroleinbiosynthesisof
PGs, catalyzing the formation of PGF2𝗼 and 9𝗼-, 11𝗽-PGF2𝗼
from PGH2 and PGD2, respectively [63]. However, none of
known functional PGFSfrom AKR1Cfamily was detected in
bovine endometrium, while the expression of PGF2𝗼 was
very high [35].
Aldoketoreductase 1B5 (AKR1B5) was the most likely
PGFS involved in the production of PGF2𝗼 in bovine
endometrium at the time of luteolysis [35]. Interestingly,
with its 20𝗼HSD activity, this enzyme can also inactivate
progesterone, another factor regulating endometrial func-
tion. Therefore, AKR1B5, an old enzyme, established with
a new function, as a functional PGFS [35]. The human
equivalent of the bovine AKR1B5 is AKR1B1 belonging to
the AKR superfamily [64]. AKR1B1 also known as the aldose
reductase is highly expressed in the placenta for glucose
metabolism and in the eye and kidney for osmotic regulation
[65]. Recently, Chapdelaine et al. [66]a c c u m u l a t e ds e v e r a l
lines of evidence supporting the hypothesis that AKR1B1 is a
functionalPGFSinthehumanendometrium.Kangetal.[67]
demonstrated AKR1B1 association with PGF2𝗼 production
in human endometrial cell lines and in decidualized stromal
cells. In a cell free system, purified AKR1B1 recombinant
protein is able to produce PGF2𝗼 from PGH2. Endometrial
cell lines transiently transfected with an expression vector
codingforAKR1B1exhibitincreasedabilitytoreleasePGF2𝗼.
In contrast, when AKR1B1 expression is knockdown with
specific siRNAs, PGF2𝗼 production is decreased. They have
foundthattheotherpotentialPGFsynthase(AKR1C3)isalso4 ISRN Physiology
expressed in endometrial cell cultures, but its contribution to
PGF2𝗼 production remains to be determined.
The endometrial release of PGF2𝗼 in response to oxy-
tocin is the initial signal triggering luteolysis in animals,
and ovarian PGF2𝗼 contributes to the luteolytic process in
primates including humans [68]. In presence of a viable
embryo, the default luteolytic signal is counteracted by an
antiluteolytic or a luteotrophic signal or a combination of
both to maintain the production of progesterone. PGF2𝗼 is
also a potent constrictor of the myometrium and uterine
blood vessels [69]. In humans, PGs interact with cytokines
and prolactin (PRL) to regulate decidualization and with
angiogenic and coagulation factors to regulate menstruation
[70].Duringthemenstrualcycle,theconcentrationofPGF2𝗼
is apparently higher than PGE2 during the secretory phase,
whereas levels of both PGs are low during the proliferative
phase. The concentrations of PGE2 remain low, whereas
PGF2𝗼 goes higher during menstruation and lower during
the implantation [71]. Recent reviews concur to state that
across species (namely human horse pig, sheep, and cow),
PGF2𝗼 and PGE2 are universally important in the regulation
of endometrial function [70, 72].
2.2. Prostaglandin F2 Receptor (PGFR). Many of uterine ef-
fects are associated with the expression and activation of
prostanoid receptors, which have been derived from in vitro
or in vivo studies involving the genetic or pharmacological
manipulation of prostanoid receptors. Some of the known
effectsofprostanoidsignallingincludeangiogenesis,prolifer-
ation, adhesion, alterations in cellular morphology, motility,
invasion [33, 73], and pain perception [74, 75].
PGF2𝗼exertsitsbiologicalfunctionthroughinteractions
with FP prostanoid receptors (PGFR). Reproductive tissues
express different classes of prostaglandin receptors [76].
PGFR is a receptor for PGF2𝗼.I ti sam e m b e ro ft h eG -
proteincoupledreceptorfamily.Maineffectsofprostaglandin
binding to the receptor are uterine (smooth muscle) contrac-
tion [77–81]. PGF2𝗼 mediates luteolysis via activation of this
receptor [40] and is also involved in modulating intraocular
pressure and smooth muscle contraction in uterus and
gastrointestinal tract sphincters. Knockout studies in mice
suggest that the interaction of PGF2𝗼 with this receptor
in ovarian luteal cells initiates luteolysis and thus induces
parturition [40].
There is evidence demonstrating that PGFR may be
regulated both during pregnancy and labour, implicating
its potential role in the parturition process. In rats, PGFR
expression in the uterus remained low through 15–20 days of
gestation, whereas at day 22 and during parturition (day 23),
PGFRexpressionsignificantlyincreased[82–84].Inaddition,
micelackingthePGFRgeneremainpregnantpostterm[40],
and administration of THG113, a PGFR antagonist, can delay
preterm birth in both mice and sheep [85, 86]. This led to the
suggestion that PGFR antagonists may prove to be of benefit
for the treatment of preterm labour [87].
2.3. Prostaglandin E2 Synthase (PGES). PGES is a terminal
prostanoid synthase that can enzymatically convert COX
product PGH2 to PGE2 [62]. PGE2 induces systemic effects
and may act as a luteotrophic or antiluteolytic agent [19].
PGE2alsoexertsanimmunomodulationthathelpstoprevent
rejection of the conceptus [20]. The accepted pathway for
the production of PGE2 involves first the generation of
PG endoperoxide H2 primarily through COX-2 and then
conversion into PGE2 via PGES. It has been observed that
PGES may be an important rate-limiting enzyme for PGE2
biosynthesis in bovine endometrium [88].
Ithasbeenreportedthatrecognitionandestablishmentof
pregnancy depends on the regulation of the balance between
PGF2𝗼 as the luteolytic signal and PGE2 as the antiluteolytic
or luteotrophic signal. In this respect, the relative production
of PGE2 and PGF2𝗼 may be more important than the abso-
lute production of each PG. The PGE2/PGF2𝗼 ratio can be
modulatedinfavourofPGE2andestablishmentofpregnancy
by three different pathways: (1) the well-accepted hypothesis
of a decrease in the production of PGF2𝗼;c o n v e r s i o no f
PGE2 into PGF2𝗼 by a putative 9-keto-prostaglandin E2
reductase and (2) an increase in PGE2 through the stimu-
lation of PGE synthase. Asselin et al. [89, 90]r e p o r t e dt h a t
PGE2 production is increased in both types of endometrial
cells following treatment with recombinant ovine interferon
tau (IFNT), a key factor for establishment of pregnancy
recognition signal. In addition, IFNT silences expression
of estrogen receptor alpha which prevents upregulation of
oxytocin receptor (OXTR) expression, which is required for
the endometrium to generate oxytocin-dependent luteolytic
pulsesofprostaglandinF2𝗼(PGF2𝗼)inr es po n set oo xyt ocin
from the CL and/or posterior pituitary in nonpregnant ewes.
In this way, IFNT maintains CL function for continued
production of progesterone, the unequivocal hormone of
pregnancy that stimulates and maintains endometrial func-
tions necessary for conceptus survival and growth in the
uterus [91]. Dorniak et al. [92]s u p p o r t e dt h eh y p o t h e s i s
that PGs synthesized and secreted by the conceptus act in
paracrine alone or in concert with IFNT and progesterone to
coordinatelyregulateendometrialfunctionsthatgoverncon-
ceptus growth and elongation during the peri-implantation
periodofpregnancyinsheep.Therefore,PGsandIFNTfrom
the conceptus coordinately regulate endometrial functions
important. In epithelial cells, the alteration in PG production
was such that the primary PG produced was changed from
PGF2𝗼 to PGE2. Arosh et al. [27] have shown that the
expression of PGES mRNA closely followed that of COX-
2 during the bovine estrous cycle. Presence of PGES and
its modulation under conditions known to influence PG
production in bovine endometrial was reported for the first
time by Parent et al. [88].
2.4.Cyclooxygenase(COX)2. PGsaregeneratedviatheCOX
pathway,andCOXistherate-limitingenzymeforconversion
of arachidonic acid into PGH2 [30, 93]. COX exists in to two
isoforms that are encoded by two separate genes, COX1 and
COX-2,whicharealsoknownasprostaglandinendoperoxide
H synthases (PGHS)-1 and (PGHS)-2 [30]. These enzymes
are responsible for the conversion of arachidonic acid into
PGH2. Although COX1 is a constitutively expressed enzyme
in a variety of cell types, COX-2 is the inducible enzymeISRN Physiology 5
Table1:Inourknowledge,statusofstudyformRNAexpressionpatternofsomeimportantgenesregulatingPGsynthesisindifferentspecies.
Name of genes
Expression reported in endometrium of different mammalian species, across estrous/menstruation cycle (in vivo)
Human Monkey Horse Pig Cow Sheep Goat
AKR1B5 ✓
[53] XX ✓
[54]
✓
[35, 55] XX
PGFS/AKR1C3 ✓
[53] X ✓
[56]
✓
[52, 57]
✓
[55]
✓
[44] X
PGFR ✓
[58] X ✓
[59] X ✓
[55] XX
PGES ✓
[60]
✓
[53]
✓
[56]
✓
[52, 57]
✓
[27, 55]
✓
[44] X
COX-2 ✓
[61]
✓
[62]
✓
[54]
✓
[28]
✓
[27, 53]
✓
[13] X
Symbol represents, reports, ✓:a v a i l a b l e ,X :n o ta v a i l a b l e .
that plays role in various pathological and physiological
conditionsinanimaltissues.AlthoughCOX1deficientfemale
m i c ea r ef e r t i l e ,t h e yh a v es p e c i fi cd e f e c t si np a r t u r i t i o n ,
whereas COX-2 deficient female mice are infertile with
abnormalities in ovulation, fertilization, implantation, and
decidualization [36, 38, 94]. The requirement of COX-2 for
normal blastocyst implantation and decidualization in mice
is due to the role of COX-2-derived PGs in regulation of
vascularendothelialgrowthfactorandangiopoietinsignaling
thatinfluenceuterinevascularpermeabilityandangiogenesis
[61,88,95].Parentetal.[32]havecorrelatedtheexpressionof
PGES with that of COX-2, which is an important enzyme for
the production of PGE2 in bovine endometrium. Increasing
this production will modulate the PGE2/PGF2𝗼 ratio and
contribute to establishment of pregnancy.
3. Spatiotemporal Expression of
AKR1B5, AKR1C3, PGFR, PGES, and
COX-2 Genes in Endometrium, across
Estrus/Menstruation Cycle
Although the ovine model has greatly advanced our under-
standing of how the fate of the corpus luteum is controlled,
it is clear that the mechanisms involved in the maternal
recognition of pregnancy vary considerably from one species
to another [17, 18, 96]. Therefore, spatiotemporal expression
of these genes (at transcript level) in endometrium, across
estrus/menstruation cycle, was studied extensively in differ-
ent species, namely, human, monkey, horse, pig, and sheep
(Table1).Thereproductivepatternofthegoatisrathersimilar
to the sheep in many respects, but there are two important
differences between these two species. First, the oestrous
cycle length in the goat is longer (19–21 days) as compared
withthesheep(16–17days).Second,thegoatreliesexclusively
on progesterone secreted by the CL for the maintenance of
pregnancy,sincethegoatplacenta,unlikethesheep,doesnot
produce progesterone [17]. Despite having their significant
role for the regulation of estrus cycle and maintenance of
pregnancy, the above review suggested that the goat is one of
the few domestic species in which these genes are still to be
studied.
4. Conclusions
Endometrial PGs (PGF2𝗼 and PGE2) synthesis, secretion
and associated genes for their function, is being discussed in
this review. Both PGF2𝗼 and PGE2 function to establish and
maintain the pregnancy by their luteolysis and luteotropic
nature. The expression of these genes has been studied in
various species, namely, human, monkey, horse, pig, cow,
and sheep. However, in goat these genes and their expression
are still to be studied. So, there is the need to explore
the expression pattern of these genes in this important
domestic species too. Along with these, the particular ratio
of PGE2/PGF2𝗼 is also unclear, which ultimately decides the
microenvironment of uterus. In conclusion, the answer of
thesequestionsweleftcansolvetheproblemsinreproductive
performance.
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